Menu
Not yet recruiting NCT04669093

Individual Differences in Placebo Analgesic Effects

No phase Interventional Healthy

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Placebo cream- "promotion" suggestion, Placebo cream- "prevention" suggestion, Control cream.
Who it may be relevant to
Registry conditions: Healthy. Basic parameters: 18 years — 55 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Person by Situation Interaction: Matching Suggestions to Participants' Motivational Styles

Overview

This study examines the effects of placebo suggestions tailored to match or mismatch individual participants' motivational styles-an issue of person-situation 'fit' with important effects in public health settings, but which has been ignored in past research.

Interventions

  • Behavioral Placebo cream- "promotion" suggestion
    Over-the-counter hand cream will be applied to participants' skin, but they will be told that they are given a highly efficient topical analgesic cream. The suggestion will be based on a "promotion" approach (promoting good feelings).
  • Behavioral Placebo cream- "prevention" suggestion
    Over-the-counter hand cream will be applied to participants' skin, but they will be told that they are given a highly efficient topical analgesic cream. The suggestion will be based on a "prevention" approach (preventing pain).
  • Behavioral Control cream
    In a control condition, with the same cream as in the placebo interventions, participants will be instructed that the cream is a control cream with no effects.

Primary outcome measures

  • Changes in subjective ratings of acute thermal pain [Time frame: Measured repeatedly, immediately after thermal stimuli on the day of participation. Averaged and compared across interventions.]
  • Changes in subjective ratings of pain expectations [Time frame: Measured repeatedly, immediately before thermal stimuli on the day of participation. Averaged and compared across interventions.]
Secondary outcome measures (4)
  • Facial expressions [Time frame: Immediate response measured during painful stimulation on the day of participation. Averaged and compared across interventions.]
  • Thermal imaging of the face [Time frame: Immediate response measured during painful stimulation on the day of participation. Averaged and compared across interventions.]
  • Changes in skin conductance response measured with a Biopac device [Time frame: Immediate response measured during painful stimulation on the day of participation. Averaged and compared across interventions.]
  • Changes in heart rate measured with a Biopac device [Time frame: Immediate response measured during painful stimulation on the day of participation. Averaged and compared across interventions.]

Eligibility criteria

Inclusion criteria

  • Healthy participants
  • Dominant promotion focus or dominant prevention focus (based on our screening)

Exclusion criteria

  • Currently or recently suffered from chronic pain (based on screening)
  • Cannot tolerate heat pain applied to the forearm, based on a calibration task at the beginning of the experiment

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Crossover
Masking
Single blind
Primary purpose
Basic science

Study locations

United States · 1 center
  • Dartmouth College — Hanover

Identifiers

NCT: NCT04669093 · 230138

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗